Competitive Intelligence

Clinical Trials Monitor

2 projects tracked · latest scans below

danbury

Heme-Onc Competitive Landscape (PCNSL / PV / TCL / GvHD)

3 signals

June 5, 2026

Lacutamab Phase 2 PTCL trial (NCT04984837) closed enrollment — RECRUITING → ACTIVE_NOT_RECRUITING (v8, 2026-06-02) — signaling a data readout is approaching; Novartis Phase 3 MF trial rapidly expanding sites.

View report →

painswick

Obesity and Type 2 Diabetes

1 signal

June 5, 2026

Novo Nordisk registered a large 35,000-participant real-world semaglutide study (NCT07627074) on 2026-06-04; all other in-window updates were routine batch verification sweeps.

View report →

Generated by Claude Code + ClinicalTrials.gov MCP · clinicaltrials.gov
Rendered: 2026-06-05T12:25:50.790Z